Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment

This publication has 22 references indexed in Scilit:

• The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)
  European Heart Journal, 2005
• ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
  JACC, 2005
• Impact of β-blocker therapy on functional capacity criteria for heart transplant listing
  The Journal of Heart and Lung Transplantation, 2003
• Lifetime Risk for Developing Congestive Heart Failure
  Circulation, 2002
• Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure
  Circulation, 2002
• Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure
  JACC, 2002
• The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure
  JACC, 2000
• Epidemiology of heart failure and ventricular dysfunction
  The Lancet, 1998
• Physicians' Survival Predictions for Patients With Acute Congestive Heart Failure
  Archives of internal medicine (1960), 1997
• Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.
  Circulation, 1991